SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-023317
Filing Date
2021-09-22
Accepted
2021-09-22 07:52:54
Documents
13
Period of Report
2021-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 41496
2 ex10-1.htm EX-10.1 59785
  Complete submission text file 0001493152-21-023317.txt   291806

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crbp-20210816.xsd EX-101.SCH 3037
4 XBRL LABEL FILE crbp-20210816_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE crbp-20210816_pre.xml EX-101.PRE 22797
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4259
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37348 | Film No.: 211268191
SIC: 2834 Pharmaceutical Preparations